How have ICUCW shares performed in 2024?

SeaStar Medical's stock was trading at $0.0304 on January 1st, 2024. Since then, ICUCW shares have increased by 193.1% and is now trading at $0.0891. View the best growth stocks for 2024 here .

Are investors shorting SeaStar Medical?

SeaStar Medical saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 3,100 shares, a decline of 80.1% from the March 31st total of 15,600 shares. Based on an average daily trading volume, of 214,400 shares, the days-to-cover ratio is currently 0.0 days. View SeaStar Medical's Short Interest .

How do I buy shares of SeaStar Medical?

Shares of ICUCW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ICUCW

SeaStar Medical (ICUCW) Stock Price, News & Analysis

→ Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad)

Free ICUCW Stock Alerts

$0.09

0.00 (0.00%)

(As of 04/26/2024 ET)

Compare

Today's Range: $0.09
▼
$0.09
50-Day Range: $0.09
▼
$0.35
52-Week Range: $0.01
▼
$0.43

Volume: 101,312 shs
Average Volume: 183,666 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Social Media

Get SeaStar Medical alerts:

Ad Banyan Hill Publishing

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

ICUCW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ICUCW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive ICUCW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:ICUCW
CUSIP: N/A
CIK: 1831868
Web: www.seastarmedical.com
Phone: 844-427-8100
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Eric Schlorff (Age 51)
CEO, President & Executive Director
Comp: $690k
Dr. H. David Humes M.D.
Co-Founder and Managing Director
Colonel Kevin Chung FACP (Age 51)
M.D., Chief Medical Officer
Comp: $375k
Mr. David A. Green CPA (Age 61)
M.B.A., Chief Financial Officer
Tom Mullen
Vice President of Operations & Product Development

Key Competitors

View All Competitors

ICUCW Stock Analysis - Frequently Asked Questions

How have ICUCW shares performed in 2024?: SeaStar Medical's stock was trading at $0.0304 on January 1st, 2024. Since then, ICUCW shares have increased by 193.1% and is now trading at $0.0891.
View the best growth stocks for 2024 here.
Are investors shorting SeaStar Medical?: SeaStar Medical saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 3,100 shares, a decline of 80.1% from the March 31st total of 15,600 shares. Based on an average daily trading volume, of 214,400 shares, the days-to-cover ratio is currently 0.0 days.
View SeaStar Medical's Short Interest.
How do I buy shares of SeaStar Medical?: Shares of ICUCW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ICUCW) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial